The man from Mazars: Tom O’Brien on inflation, expansion and tackling the Big Four
As managing partner of Mazars, Tom O’Brien leads a growing firm in an industry in flux. In this interview, he talks about being a liquidator during the crash, his ambitions for Mazars and the outlook for the Irish economy.
As Beechbrook seizes control of Slendertone assets, the wearable tech company is now back in play
First, it went into examinership. A liquidation followed. Now, the company behind Slendertone has gone into receivership following a move by its main backer, the British lender Beechbrook Capital. The move could yet salvage the brand.
Having failed to secure a new investor, Slendertone has collapsed into liquidation
The High Court has appointed a liquidator to Galway-based wearable technology company Bio-Medical Research, the maker of Slendertone. The business had been in examinership since March but had failed to find a new investor.
Unpicking XS Direct: The €80m IPO candidate that left behind a €25m deficit
New documents lay bare the financial plight of XS Direct, revealing details of how much the main creditors, including Beach Point Capital, are owed. They also disclose efforts to sell the company’s insurance book and intellectual property.
Drugs, lawsuits and billions of dollars: Behind the scenes at Ireland’s largest ever insolvency
Mallinckrodt, a 155-year-old US pharmaceutical manufacturer, came to Ireland in 2013 to set up an intricate corporate and tax structure. After thousands of legal actions threatened to shut it down, its salvage deal has just cleared an Irish examinership.